• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Rare Disease : Episode 7

Episode 7 - Minimizing the Burden of SLE

Video

During this segment, Michelle Petri, MD, MPH, explains how systemic lupus erythematosus (SLE) burdens patients and can lead to disability under our country’s current standard of care.

Because SLE can be a life-threatening disease, as it presents in many different ways, Dr Petri concludes that the disease’s relapsing-remitting pattern can make the disease “unpredictable.”

Dr Petri explores the importance for preventive therapy and education to help improve survival. She further explains that Europe seems to be ahead of the United States in terms of treatment adherence and claims that as many as 40% of patients with lupus aren’t taking their anti-malarial therapy regularly even though the use of hydroxychloroquine can reduce flares, lupus nephritis, thrombosis, and, in 2 different studies, has been shown to improve survival.


Related Videos
Timothy Craig, DO
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Merrill H. Stewart, MD
Coral Omene, MD, PhD, sitting for a vieo interview
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.